Literature DB >> 7933156

Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection.

C T Nugent1, R M Wolcott, R Chervenak, S R Jennings.   

Abstract

The immune response to herpes simplex virus type 1 (HSV-1) infection in C57BL/6 mice includes a population of major histocompatibility complex class I-restricted cytolytic T lymphocytes (CTL) that recognize the structural glycoprotein gB. To gain insight into the importance of this CTL subpopulation in vivo, gB-specific CTL present in the regional lymph nodes after a primary infection and after a reinfection of convalescent animals were analyzed. In a primary infection, gB-specific CTL precursors (CTLp) that recognized either a cell line constitutively expressing gB or cells pulsed with the optimal Kb-restricted gB epitope 498SSIEFARL505 were present at an estimated frequency of 1/12,000 compared with a frequency of 1/3,000 for CTLp which recognized cells infected with HSV-1 itself. In convalescent mice responding to reinfection, HSV-specific CTLp were present at an estimated frequency of 1/4,000 to 1/14,000. However, gB-specific CTLp could not be detected at this site. These findings suggest that CTL specific for an immunodominant epitope contribute substantially to the primary response but may not be a component of the HSV-specific CTL population that responds rapidly to reinfection in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933156      PMCID: PMC237217     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  T cell-macrophage interactions in the immune response to herpes simplex virus: the significance of interferon-gamma.

Authors:  J M Seid; M Liberto; L Bonina; K N Leung; A A Nash
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

2.  Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen.

Authors:  Y Tanaka; M J Tevethia; D Kalderon; A E Smith; S S Tevethia
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

Review 3.  Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.

Authors:  T J Braciale; L A Morrison; M T Sweetser; J Sambrook; M J Gething; V L Braciale
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

4.  Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.

Authors:  A A Nash; A Jayasuriya; J Phelan; S P Cobbold; H Waldmann; T Prospero
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). V In vitro demonstration of SV40 TrAg in SV40 infected nonpermissive mouse cells by the lymphocyte mediated cytotoxicity assay.

Authors:  J Pretell; R S Greenfield; S S Tevethia
Journal:  Virology       Date:  1979-08       Impact factor: 3.616

7.  The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.

Authors:  V C Carter; P A Schaffer; S S Tevethia
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

8.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.

Authors:  S R Jennings; P L Rice; S Pan; B B Knowles; S S Tevethia
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.

Authors:  M J Lawman; B T Rouse; R J Courtney; R D Walker
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more
  12 in total

1.  Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.

Authors:  S C Cose; J M Kelly; F R Carbone
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

2.  In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.

Authors:  Sadik H Kassim; Naveen K Rajasagi; Xiangyi Zhao; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

Authors:  M E Wallace; R Keating; W R Heath; F R Carbone
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.

Authors:  K H Edelmann; C B Wilson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection.

Authors:  C M Jones; S C Cose; R M Coles; A C Winterhalter; A G Brooks; W R Heath; F R Carbone
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 6.  A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.

Authors:  Sherrie Divito; Thomas L Cherpes; Robert L Hendricks
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo.

Authors:  Patric Lundberg; Paula Welander; Xiao Han; Edouard Cantin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.

Authors:  Naveen K Rajasagi; Sadik H Kassim; Christina M Kollias; Xiangyi Zhao; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

Authors:  Scott N Mueller; Claerwen M Jones; Weisan Chen; Yoshihiro Kawaoka; Maria R Castrucci; William R Heath; Francis R Carbone
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.

Authors:  M A Brehm; R H Bonneau; D M Knipe; S S Tevethia
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.